Amcad Biomed CorporationTPEX: 4188

Board of Directors approved the convening of the 2022 Annual Shareholders' Meeting

· Issued by AmCad BioMed Corporation
Close
Today's Information

Provided by: AmCad BioMed Corporation
SEQ_NO 2 Date of announcement 2022/02/18 Time of announcement 15:48:40
Subject
 AmCad Board of Directors approved the convening
of the 2022 Annual Shareholders' Meeting
Date of events 2022/02/18 To which item it meets paragraph 17
Statement
1.Date of the board of directors resolution:2022/02/18
2.General shareholders' meeting date:2022/05/20
3.General shareholders' meeting location:
3F., No. 10, Shi 2nd Rd., Yangmei Dist., Taoyuan City
4.Cause for convening the meeting I.Reported matters:
(I) To report the business of 2021
(II) Audit Committee's review report
(III) Report on the Handling of Private Common Stock Cases Adopted at the
      2021 Shareholders meeting.
(IV) Amendment to the Company's"Sustainable Development Best Practice
     Principles"
(V) To report the progress of the fund use from 2015 capital increase
5.Cause for convening the meeting II.Acknowledged matters:
(I) To accept 2021 Business Report and Financial Statements
(II) To accept the proposal for loss off-setting of 2021
6.Cause for convening the meeting III.Matters for Discussion:
 Amendment to the Company's"Acquiring or disposing of asset handlers"
7.Cause for convening the meeting IV.Election matters:None
8.Cause for convening the meeting V.Other Proposals:None
9.Cause for convening the meeting VI.Extemporary Motions:None
10.Book closure starting date:2022/03/20
11.Book closure ending date:2022/05/20
12.Whether to announce proposal for profit distribution
or loss off-setting in "Status of dividend distribution
" section of MOPS:Yes
13.Please explain the reason for not announcing proposal
for profit distribution or loss off-setting:None
14.Any other matters that need to be specified:None

Company analysis

Earlier from Amcad Biomed

All Amcad Biomed news releases